Trade

with

Teva Pharmaceutical Industries Ltd
(NYSE: TEVA)
AdChoices
53.81
+0.56
+1.05%
After Hours :
-
-
-

Open

52.99

Previous Close

53.25

Volume (Avg)

380.21k (3.80M)

Day's Range

52.88-53.84

52Wk Range

36.26-55.70

Market Cap.

44.14B

Dividend Rate (Yield )

1.20 (2.28%)

Beta

0.63

Shares Outstanding

854.00M

P/E Ratio (EPS)

16.84 (3.04)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 20.31B

    • Net Income

    • 1.27B

    • Market Cap.

    • 44.14B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 12.58

    • PEG (Price/Earnings Growth) Ratio

    • 1.41

    • Beta

    • 0.63

    • Forward P/E

    • 10.87

    • Price/Sales

    • 2.21

    • Price/Book Value

    • 1.93

    • Price/Cash flow

    • 13.70

      • EBITDA

      • 3.21B

      • Return on Capital %

      • 5.48

      • Return on Equity %

      • 11.47

      • Return on Assets %

      • 5.48

      • Book Value/Share

      • 27.56

      • Shares Outstanding

      • 854.00M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.30 (8/19/2014)

      • Dividend Declaration Date

      • 7/31/2014

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 60.00

        • Credit Rating

        • A-

        • Analysts

        • 9

        • EPS Estimate

        • 3.65

        • Cashflow Estimate

        • 4.76

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 2.50

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -35.40

          • -26.33

          • Net Income

            Q/Q (last year)

          • -

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 12.88

          • -5.42

          • Net Income

            5-Year Annual Average

          • 14.90

          • 3.16

          • Dividends

            5-Year Annual Average

          • 21.54

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 52.99

            • 64.72

            • Pre-Tax Margin

            • 14.43

            • 13.77

            • Net Profit Margin

            • 12.58

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 53.30

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 13.90

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • 13.20

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.39

              • 0.33

              • Current Ratio

              • 1.14

              • 1.52

              • Quick Ratio

              • 0.53

              • 0.87

              • Interest Coverage

              • -

              • 6.77

              • Leverage Ratio

              • 1.99

              • 1.91

              • Book Value/Share

              • 27.56

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 17.04

                • 63.69

                • P/E Ratio 5-Year High

                • 21.40

                • 237.47

                • P/E Ratio 5-Year Low

                • 11.53

                • 19.71

                • Price/Sales Ratio

                • 2.14

                • 3.57

                • Price/Book Value

                • 1.88

                • 3.35

                • Price/Cash Flow Ratio

                • 13.70

                • 21.41

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 11.47

                    (10.90)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • 5.48

                    (5.60)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • 7.52

                    (8.30)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • 57.40k

                  • 27.79k

                  • Inventory Turnover

                  • 1.88

                  • 1.80

                  • Asset Turnover

                  • 0.44

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  1.65B
                  Operating Margin
                  8.12
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  13.70
                  Ownership

                  Institutional Ownership

                  59.79%

                  Top 10 Institutions

                  23.53%

                  Mutual Fund Ownership

                  31.50%

                  Float

                  -

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • VA CollegeAmerica EuroPacific Growth

                  •  

                    12,810,300

                  • 0.00

                  • 1.50

                  • Franklin Mutual Global Discovery Fund

                  •  

                    8,737,113

                  • 0.00

                  • 1.02

                  • VA CollegeAmerica Cap World Gr and Inc

                  •  

                    8,452,000

                  • -10.78

                  • 0.99

                  • Vanguard Health Care Fund

                  •  

                    7,344,400

                  • -40.54

                  • 0.86

                  • Franklin Mutual Shares Fund

                  •  

                    6,224,949

                  • 0.00

                  • 0.73

                  • Templeton Growth Fund

                  •  

                    6,159,610

                  • 0.64

                  • 0.72

                  • VA CollegeAmerica Invmt Co of America

                  •  

                    4,100,000

                  • 0.00

                  • 0.48

                  • Fidelity® Diversified International Fund

                  •  

                    3,961,400

                  • 0.00

                  • 0.46

                  • AllianzGI NFJ Dividend Value Fund

                  •  

                    3,572,200

                  • 0.00

                  • 0.42

                  • Fidelity® Contrafund® Fund

                  •  

                    3,522,400

                  • 6.26

                  • 0.41

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Fidelity Management and Research Company

                  •  

                    37,909,048

                  • +47.71%

                  • 4.44

                  • Capital Research Global Investors

                  •  

                    32,895,152

                  • -24.18%

                  • 3.85

                  • Franklin Mutual Advisers, LLC

                  •  

                    24,051,510

                  • -1.75%

                  • 2.82

                  • Invesco Advisers, Inc

                  •  

                    18,158,475

                  • +39.78%

                  • 2.13

                  • Templeton Global Advisors Limited

                  •  

                    17,952,094

                  • +34.61%

                  • 2.10

                  • Mondrian Investment Partners Ltd

                  •  

                    17,315,878

                  • -1.78%

                  • 2.03

                  • Lazard Asset Management LLC

                  •  

                    15,283,002

                  • +205.99%

                  • 1.79

                  • Wellington Management Company, LLP

                  •  

                    14,029,142

                  • -56.65%

                  • 1.64

                  • PointState Capital LP

                  •  

                    12,475,105

                  • -2.05%

                  • 1.46

                  • Barrow, Hanley, Mewhinney & Strauss LLC.

                  •  

                    10,868,770

                  • -18.50%

                  • 1.27

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Speculative Growth

                  Style

                  Large Value

                  Teva Pharmaceutical Industries Ltd was incorporated in Israel on February 13, 1944. The Company manufactures generic pharmaceutical products. It operates in business in two segments such as generic products, which includes chemical a...morend therapeutic equivalents of originator pharmaceuticals in a variety of dosage forms, including tablets, capsules, ointments, creams, liquids, injectables and inhalants, as well as API business; and specialty products, which includes several core franchises, medicines for CNS disorders (with a strong emphasis on MS, neurodegenerative disorders, and pain) and respiratory medicines, as well as other areas such as oncology and women’s health. In addition to these two segments, the Company has other activities, primarily PGT Healthcare, OTC joint venture with P&G, distribut...moreion services primarily in Israel and Hungary, and sales of medical devices. The Company, along with its subsidiaries operates in approximately 60 countries. It develops, manufactures and sell generic pharmaceutical products in a variety of dosage forms, including tablets, capsules, ointments, creams, liquids, injectables and inhalants. Specialty medicines business, which is focused on delivering solutions to patients and providers via medicines, devices and services in all key regions and markets around the world, includes several core therapeutic areas, medicines for CNS disorders (with a strong emphasis on MS, neurodegenerative disorders, and pain) and respiratory medicines. Some of its products are Copaxone, Azilect & Provigil, among others. The Company markets approximately 375 generic products in more than 1,100 dosage strengths and packaging sizes, including oral, injectables and inhaled products. The Company is subject to extensive regulation by the United States federal government, principally by the FDA and the Drug Enforcement Administration (“DEA”).lessless

                  Key People

                  Carlo De Notaristefani,PhD

                  CEO, Divisional/President, Divisional

                  Judith Vardi

                  CEO, Geographical/President, Geographical

                  Mr. Erez Vigodman

                  Director/President/CEO

                  Robert Koremans

                  CEO, Geographical/President, Geographical

                  Mr. Allan Oberman

                  CEO, Subsidiary/President, Subsidiary

                  • Teva Pharmaceutical Industries Ltd

                  • 5 Basel Street

                  • Petach Tikva, 4951033

                  • ISR.Map

                  • Phone: +972 39148171

                  • Fax: +972 39148678

                  • tevapharm.com

                  Incorporated

                  1944

                  Employees

                  45,000

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: